An explainable model to support the decision about the therapy protocol for AML
Acute Myeloid Leukemia (AML) is one of the most aggressive types of hematological neoplasm. To support the specialists' decision about the appropriate therapy, patients with AML receive a prognostic of outcomes according to their cytogenetic and molecular characteristics, often divided into three risk categories: favorable, intermediate, and adverse. However, the current risk classification has known problems, such as the heterogeneity between patients of the same risk group and no clear definition of the intermediate risk category. Moreover, as most patients with AML receive an intermediate-risk classification, specialists often demand other tests and analyses, leading to delayed treatment and worsening of the patient's clinical condition. This paper presents the data analysis and an explainable machine-learning model to support the decision about the most appropriate therapy protocol according to the patient's survival prediction. In addition to the prediction model being explainable, the results obtained are promising and indicate that it is possible to use it to support the specialists' decisions safely. Most importantly, the findings offered in this study have the potential to open new avenues of research toward better treatments and prognostic markers.
Code (0)
등록된 구현이 없습니다.
Tasks
Survival PredictionSimilar Papers 제목 키워드 기반
The dose-dense principle in chemotherapy
Chemotherapy is a class of cancer treatment that uses drugs to kill cancer cells. A typical chemotherapeutic protocol consists of several drugs delivered in cycles of three weeks. We present mathematical analyses demonst…
Bayesian data assimilation to support informed decision-making in individualised chemotherapy
An essential component of therapeutic drug/biomarker monitoring (TDM) is to combine patient data with prior knowledge for model-based predictions of therapy outcomes. Current Bayesian forecasting tools typically rely onl…
Decision MakingUncertainty QuantificationA survey of open questions in adaptive therapy: bridging mathematics and clinical translation
Adaptive therapy is a dynamic cancer treatment protocol that updates (or "adapts") treatment decisions in anticipation of evolving tumor dynamics. This broad term encompasses many possible dynamic treatment protocols of …
A PBN-RL-XAI Framework for Discovering a "Hit-and-Run" Therapeutic Strategy in Melanoma
Innate resistance to anti-PD-1 immunotherapy remains a major clinical challenge in metastatic melanoma, with the underlying molecular networks being poorly understood. To address this, we constructed a dynamic Probabilis…
Reinforcement LearningBridging the Skills Gap: Evaluating an AI-Assisted Provider Platform to Support Care Providers with Empathetic Delivery of Protocolized Therapy
Despite the high prevalence and burden of mental health conditions, there is a global shortage of mental health providers. Artificial Intelligence (AI) methods have been proposed as a way to address this shortage, by sup…